Ravelcare IPO opens for bidding on Dec 1; check price band, key dates, GMP

Ravelcare IPO: The initial public offering (IPO) of beauty and personal care brand Ravelcare will open for public subscription on Monday, December 1, 2025. The ₹24.1 crore SME issue comprises a fresh issue of 1.9 million equity shares. There is no offer-for-sale (OFS) component.

 

According to the red herring prospectus (RHP), the company has reserved not more than 50 per cent of the issue for qualified institutional buyers (QIBs), not less than 35 per cent for retail investors, and 15 per cent for non-institutional investors (NIIs).  

Here are the key details of Ravelcare IPO:

Ravelcare IPO price band, lot size

Ravelcare has set the price band for its IPO in the range of ₹123 to ₹130 per equity share. The minimum lot size for an application is 1,000 shares. A retail investor would require a minimum investment amount of ₹260,000, considering the upper price band, to bid for two lots. The minimum investment required for high-net-worth individuals (HNIs) is 390,000 for three lots or 3,000 shares. 

Ravelcare IPO key dates

According to the RHP, the three-day subscription window will, tentatively, close on Wednesday, December 3, 2025. The basis of the allotment of shares is likely to be finalised on Thursday, December 4, 2025. Shares of Ravelcare will be listed on the BSE SME platform, tentatively, on Monday, December 8, 2025.

Ravelcare IPO registrar, lead manager

Kfintech Technologies is the registrar of the issue. Marwadi Chandrana Intermediaries Brokers is the sole book-running lead manager of the issue.

Ravelcare IPO GMP

On Wednesday, November 26, the unlisted shares of Ravelcare were trading at ₹146, up ₹16 or 12.3 per cent against the upper end price, according to sources tracking unofficial markets.

Ravelcare IPO objective

According to the red herring prospectus (RHP), the company plans to utilise ₹11.5 crore from the net issue proceeds for marketing and advertisement expenses, and ₹7.8 crore for setting up a new manufacturing facility at Mauje-Peth in Amravati. The remaining funds will be used for general corporate purposes. 

Ravelcare financial overview

In the financial year 2024-25 (FY25), Ravelcare reported revenue from operations of ₹24.97 crore, up 13 per cent from ₹22.08 crore in the previous financial year. The company's earnings before interest, tax, depreciation and amortisation stood at ₹6.81 crore, up from ₹6.64 crore. Its profit after tax (PAT) stood at ₹5.25 crore, up 4.6 per cent from ₹5.02 crore in the FY24.